Alphabet Inc. — 13F Holdings & Portfolio

CIK 1652044 · latest 13F-HR filed 2026-11-06

Alphabet Inc. manages $88.35B in 13F-reported U.S. long-equity assets across 31 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are SPCX (94.78%), CME (1.03%), PL (0.65%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 4 new positions and exited 3; 8 existing positions rose in reported value and 15 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$88.35B

Long-equity book

Holdings
31

Distinct positions

Period
2026-09-30

Filed 2026-11-06

Q/Q Activity
+4 / −3 / ↑8 / ↓15

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 99.5%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 8 →

Top Trims

Show all 15 →

Alphabet Inc. Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 SPACE EXPLORATION TECHN CORP SPCX 84615Q103 $83.73B 94.78% 555,043,560 SH
2 CME GROUP INC CME 12572Q105 $912.7M 1.03% 3,484,020 SH
3 PLANET LABS PBC PL 72703X106 $577.7M 0.65% 35,248,893 SH
4 ARM HOLDINGS PLC ARM 042068205 $568.0M 0.64% 1,960,784 SH
5 REVOLUTION MEDICINES INC RVMD 76155X100 $548.8M 0.62% 2,673,909 SH
6 QUALCOMM INC QCOM 747525103 $547.9M 0.62% 2,976,982 SH
7 AST SPACEMOBILE INC ASTS 00217D100 $526.4M 0.60% 8,943,486 SH
8 FRESHWORKS INC FRSH 358054104 $159.3M 0.18% 12,457,273 SH
9 PARABILIS MEDICINES INC PBLS 698955101 $158.9M 0.18% 4,919,498 SH
10 TEMPUS AI INC TEM 88023B103 $127.0M 0.14% 1,551,102 SH
11 UIPATH INC PATH 90364P105 $90.3M 0.10% 7,034,337 SH
12 PRIME MEDICINE INC PRME 74168J101 $50.7M 0.06% 16,562,498 SH
13 PAYPAY CORP PAYP 70450C101 $49.1M 0.06% 3,125,000 SH
14 MAZE THERAPEUTICS INC MAZE 578784100 $37.7M 0.04% 1,388,583 SH
15 FREENOME INC FRNM 35661P100 $31.8M 0.04% 2,022,131 SH
16 NEUTRON HOLDINGS INC LIME 64125S104 $27.7M 0.03% 983,326 SH
17 NEUTRON HOLDINGS INC LIME 64125S104 $25.8M 0.03% 915,622 SH
18 RELAY THERAPEUTICS INC RLAY 75943R102 $25.5M 0.03% 1,410,029 SH
19 FRESHWORKS INC FRSH 358054104 $24.0M 0.03% 1,879,370 SH
20 FERVO ENERGY CO FRVO 31556C106 $23.9M 0.03% 1,760,732 SH
21 ETHOS TECHNOLOGIES INC LIFE 29765A101 $19.2M 0.02% 571,907 SH
22 OBSIDIAN THERAPEUTICS INC OBX 67448A106 $16.8M 0.02% 1,224,869 SH
23 OSCAR HEALTH INC OSCR 687793109 $14.9M 0.02% 481,988 SH
24 BRIDGEBIO ONCOLOGY THERAPEUT BBOT 107924102 $11.6M 0.01% 2,823,126 SH
25 SANA BIOTECHNOLOGY INC SANA 799566104 $8.2M 0.01% 2,812,500 SH
26 BEAM THERAPEUTICS INC BEAM 07373V105 $7.9M 0.01% 321,604 SH
27 VERA THERAPEUTICS INC VERA 92337R101 $7.8M 0.01% 241,264 SH
28 FIGMA INC FIG 316841105 $4.5M 0.01% 215,582 SH
29 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $4.4M 0.01% 372,474 SH
30 LYELL IMMUNOPHARMA INC LYEL 55083R203 $2.9M 0.00% 293,256 SH
31 HYPERFINE INC HYPR 44916K106 $728.0K 0.00% 898,720 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-06 $88.35B 31 0001652044-26-000086
2026-06-30 2026-08-07 $99.08B 29 0001652044-26-000073
2026-03-31 2026-05-08 $4.02B 27 0001652044-26-000051
2025-12-31 2026-02-13 $2.58B 32 0001652044-26-000023
Filer Information
Address
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW, CA 94043
Phone
(650) 253-0000
Filing Manager
Alphabet Inc.
Mountain View, CA
Signatory
Marsida Saraci
VP, Corporate Controller and Principal Accounting Officer